$INCR News

InterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?

InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages

InterCure Ltd. Announces 1-for-5 Reverse Share Split

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds

InterCure Enters Private Placement With Its CEO And Other Shareholders For Commitments Of ~$7.4M, With Option To Increase To ~$18.6M

InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition

InterCure Reports Growing Demand In Germany And Evaluates Opportunities In Regulated U.S. Medical Cannabis Markets

InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow

InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement

InterCure Ltd. Receives Nasdaq Non-Compliance Notice, Granted Until August 24, 2026 To Regain Compliance

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million

InterCure Posts Preliminary NIS 265M Revenue For 2025, An 11% YoY Rise, With 2H Revenue Nearly 20% Higher Than Prior Year

Trump's Marijuana Reclassification Looks Set To Send This Cannabis ETF Soaring: Big Surge In Momentum

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

InterCure Enters Into Definitive Share Purchase Agreement And Collaboration Agreement With Cannasoul To Advance Cannabis Science And Pharmaceutical Innovation

Intercure H1 EPS $0.01 Up From $0.00 YoY, Sales $36.292M Miss $66.530M Estimate

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

Middle Eastern Penny Stocks With Market Caps Over US$1M

InterCure Enters Premium US Cannabis Market With ISHI Deal